The effect of curcumin on neurological complications of diabetes and HbA1c levels

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130811014330N6

Enrollment

120

Registered

2019-06-02

Start date

2018-04-21

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic individuals with neuropathic disorders. Type 2 diabetes mellitus with neurological complications

Interventions

Intervention 1: "Intervention :"This group receives 1 capsule of sinacurcumin every day.at the end of the 3-month period, a laboratory profile similar to the beginning of the course are created for ea

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetes mellitus with neuropathy (gloves and socks) Age range of 70-18 years, at least five years with illness The same type of medication used, Taking oral medicine

Exclusion criteria

Exclusion criteria: Age over 70 years and under 18 years Taking insulin

Design outcomes

Primary

Measure	Time frame
HbA1c. Timepoint: before and after using curcumin. Method of measurement: electrophoresis.	—

Secondary

Measure	Time frame
2. The lab profile includes Lip a, BUN, U / A, Cr, FBS, TG, TC, HDL, LDL. Timepoint: Before and after using curcumin. Method of measurement: Spectrophotometry using an autoanalyzer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamidreza Rahimi

Mashhad university of medical sciences

rahimihr@mums.ac.ir+98 51 3800 2301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026